Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population

Mechanisms of Ageing and Development

Volumn 133, Issue 4, 2012, Pages 127-132

  Mittal, Rama Devi ^a   Mandal, Raju Kumar ^a   Gangwar, Ruchika ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

BER genes; Bladder cancer; Haplotype; Polymorphism; Prostate cancer

Indexed keywords

TUMOR MARKER;

ADULT; AGED; APE1 GENE; ARTICLE; BLADDER CANCER; BONE METASTASIS; CANCER GRADING; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXCISION REPAIR; EXON; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; OGG1 GENE; ONCOGENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TUMOR VOLUME; XRCC1 GENE;

AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA GLYCOSYLASES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84860754919     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2011.10.002     Document Type: Article

References (42)

1. Agalliu I., Kwon E.M., Salinas C.A., Koopmeiners J.S., Ostrander E.A., Stanford J.L. Genetic variation in DNA repair genes and PCa risk: results from a population-based study. Cancer Causes Control 2010, 21:289-300.
2. Arizono K., Osada Y., Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn. J. Clin. Oncol. 2008, 38:86-191.
3. Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst. 2000, 92:874-897.
4. Caldecott K.W. XRCC1 and DNA strand break repair. DNA Repair (Amst) 2003, 2:955-969.
5. Campalans A., Marsin S., Nakabeppu Y., O'connor T.R., Boiteux S., Radicella J.P. XRCC1 interactions with multiple DNA glycosylases: a model for its recruitment to base excision repair. DNA Repair (Amst) 2005, 4:826-835.
6. Canbay E., Agachan B., Gulluoglu M., Isbir T., Balik E., Yamaner S., Bulut T., Cacina C., Eraltan I.Y., Yilmaz A., Bugra D. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res. 2010, 30:1359-1364.
7. Chacko P., Rajan B., Joseph T., Mathew B.S., Pillai M.R. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res. Treat. 2005, 89:15-21.
8. Colombel M., Soloway M., Akaza H. Epidemiology, staging, grading and risk stratification of bladder cancer. Eur. Urol. Suppl. 2008, 7:618-626.
9. Demple B., Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu. Rev. Biochem. 1994, 63:915-948.
10. Dhillon V.S., Yeoh E., Fenech M. DNA repair gene polymorphisms and prostate cancer risk in South Australia - results of a pilot study. Urol. Oncol. 2009, (November).
11. Gil J., Ramsey D., Stembalska A., Karpinski P., Pesz K.A., Laczmanska I., Leszczynski P., Grzebieniak Z., Sasiadek M.M. The C/A polymorphism in Intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol. Biol. Rep. 2011, (May).
12. Gu D., Wang M., Wang M., Zhang Z., Chen J. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies. Mutagenesis 2009, 24:507-512.
13. Gleason D.F., Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 1974, 111:58-64.
14. Hadi M.Z., Coleman M.A., Fidelis K., Mohrenweiser H.W., Wilson DM Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res. 2000, 28:3871-3879.
15. Hirata H., Hinoda Y., Tanaka Y., Okayama N., Suehiro Y., Kawamoto K., Kikuno N., Majid S., Vejdani K., Dahiya R. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur. J. Cancer 2007, 43:231-237.
16. Hsu F.C., Sun J., Wiklund F., Isaacs S.D., Wiley K.E., Purcell L.D., Ago Z., Stating P., Zhu Y., Kim S.T., Zhang Z., Liu W., Chang B.L., Walsh P.C., Duggan D., Carp ten J.D., Isaacs W.B., Groẅ berg H., Up J., Zen S.L. A novel prostate cancer susceptibility locus at 19q13. Cancer Res. 2009, 69:2720-2723.
17. Hu Z., Ma H., Chen F., Weir Q., Sheen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidermal. Biomarkers Prep. 2005, 14:1810-1818.
18. Hu J.J., Mohrenweiser H.W., Bell D.A., Leaden S.A., Miller M.S. Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol. Appl. Pharmacol. 2002, 185:64-73.
19. Hu J.J., Smith T.R., Miller M.S., Mohrenweiser H.W., Golden A., Case L.D. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001, 22:917-922.
20. Ito H., Matsuo K., Jamaica N., Mitsudomi T., Sugar T., Saito T., Yasue T., Lee K.M., Kang D., You K.Y., Sato S., Ueda R., Tajima K. Gene - environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 2004, 25:1395-1401.
21. Jiao X., Huang J., Wu S., Live M., Hu Y., Jianfu, Su X., Lou C., Ce B. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int. J. Cancer 2007, 121:501-505.
22. Karahalil B., Kocabas N.A., Ozçelik T. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res. 2006, 26:4955-4958.
23. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.R., Sugimura H., Nohmi T., Kasai H., Yokota J. Genetic polymorphisms and alternative splicing on the hOGG1 gene that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225.
24. Le, Marchand L., Donlon T., Lum-Jones A., Seifried A., Wilkens L.R. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidermal. Biomarkers Prep. 2002, 4:409-412.
25. Lei Y.C., Hwang S.J., Chang C.C., Kuo H.W., Lou J.C., Chang M.J. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat. Res. 2002, 519:93-101.
26. Linn J.F., Sesterhann I., Mostofi F.K., Schoenberg M. The molecular characteristics of bladder cancer in young patients. J. Urol. 1998, 159:1493-1496.
27. Li Z., Guan W., Li M.X., Zhong Z.Y., Qian C.Y., Yang X.Q., Liao L., Li Z.P., Wang D. Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population. Arch. Med. Res. 2011, 42:226-234.
28. Li H., Hao X., Zhang W., Weir Q., Chen K. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidermal. Biomarkers Prep. 2008, 17:1739-1745.
29. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
30. Pachkowski B.F., Winkel S., Kubota Y., Swenberg J.A., Millikan R.C., Nakamura J. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res. 2006, 66:2860-2868.
31. Pardini B., Naccarati A., Novotny J., Smerhovsky Z., Vodickova L., Polakova V., Hanova M., Slyskova J., Tulupova E., Kumar R., Bortlik M., Barale R., Hemminki K., Vodicka P. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat. Res. 2008, 638:146-153.
32. Parkin D.M. The global burden of urinary bladder cancer. Scand. J. Urol. Nephrol. Suppl. 2008, 218:12-20.
33. Rosenquist T.A., Zharkov D.O., Grollman A.P. Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7429-7434.
34. Shields P.G., Harris C.C. Molecular epidemiology and the genetics of environmental cancer. JAMA 1991, 266:681-687.
35. Sinha R., Anderson D.E., McDonald S.S., Greenwald P. Cancer risk and diet in India. J. Postgrad. Med. 2003, 49:222-228.
36. Wang M., Qin C., Zhu J., Yuan L., Fu G., Zhang Z., Yin C. Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol. 2010, 29:303-311.
37. Wang Y., Spitz M.R., Zhu Y., Dong Q., Shete S., Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003, 2:901-908.
38. Wang Y., Yang H., Li H., Li L., Wang H., Liu C., Zen Y. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta analysis. Cancer Lett. 2009, 285:134-140.
39. Wilson D.M., Thompson L.H. Life without DNA repair. Proc. Natl. Acad. Sci. USA 1997, 94:12754-12757.
40. Wood R.D., Mitchell M., Sgouros J., Lindahl T. Human DNA repair genes. Science 2001, 291:1284-1289.
41. Yamane A., Kohno T., Ito K., Sunaga N., Aoki K., Yoshimura K., Murakami H., Nojima Y., Yokota J. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 2004, 25:1689-1694.
42. Yang Y., Zhai X.D., Ago L.B., Li S.L., Wang Z., Chen G.D. Genetic polymorphisms of DNA repair gene XRCC1 and risk of uterine leiomyoma. Mol. Cell Biochem. 2010, 338:143-147.